ReviewToxins2018
Snakebite: When the Human Touch Becomes a Bad Touch.
Review in Toxins, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
56 citing papers in PubMed.
- Under pressure: Clinical management of venom-induced compartment syndrome in snakebite-A scoping review of the global literature.PLoS neglected tropical diseases · 2026Article
- The cobras (genus Naja) of Myanmar: An updated species list with information on identification, distributions, and medical importance.PLoS neglected tropical diseases · 2026Article
- Article
- First-Aid Practices and Knowledge Regarding Snake and Scorpion Bites Among Patients Attending Onandjokwe State Hospital, Namibia: A Hospital-Based Cross-Sectional Study.Emergency medicine international · 2026Article
- Epidemiological and Clinical Behavior of Snakebite in the Pediatric Population, Associated with a Logistic Regression Model.Clinics and practice · 2025Article
- Analyzing first aid in textbooks used by non-medical and paramedical students in Nepal: A need of further attention for snakebite management!PLoS neglected tropical diseases · 2025Article
- Mapping Evidence on the Regulations Affecting the Accessibility, Availability, and Management of Snake Antivenom Globally: A Scoping Review.Tropical medicine and infectious disease · 2025Review
- Exploiting exopolysaccharides from microalgae to block the toxic in vitro effects of Bothrops sp. venom.Scientific reports · 2025Article
- Association between diabetes and disease severity in patients with venomous snakebites: A Multicenter Retrospective Analysis.PLoS neglected tropical diseases · 2025Article
- Knowledge of local snakes, first-aid and prevention of snakebites among community health workers and community members in rural Malawi: A cross-sectional study.Tropical medicine & international health : TM & IH · 2025Article
- Article
- Article
- Tiny but Mighty:Toxins · 2024Article
- Snakebite incidence and healthcare-seeking behaviors in Eastern Province, Rwanda: A cross-sectional study.PLoS neglected tropical diseases · 2024Article
- Vulnerability factors of snake bite patients in China.BMC public health · 2024Article
- Clinical Characteristics and Analysis of Risk Factors Associated with Rhabdomyolysis in Snakebite Victims.International journal of general medicine · 2024Article
- Considerations for the development of a field-based medical device for the administration of adjunctive therapies for snakebite envenoming.Toxicon: X · 2023Article
- Snakebite epidemiology, outcomes and multi-cluster risk modelling in Eswatini.PLoS neglected tropical diseases · 2023Article
- Who are the most affected by Bothrops snakebite envenoming in Brazil? A Clinical-epidemiological profile study among the regions of the country.PLoS neglected tropical diseases · 2023Review
- Compendium of medically important snakes, venom activity and clinical presentations in Ghana.PLoS neglected tropical diseases · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Many issues and complications in treating snakebite are a result of poor human social, economic and clinical intervention and management. As such, there is scope for significant improvements for reducing incidence and increasing patient outcomes. Snakes do not target humans as prey, but as our dwellings and farms expand ever farther and climate change increases snake activity periods, accidental encounters with snakes seeking water and prey increase drastically. Despite its long history, the snakebite crisis is neglected, ignored, underestimated and fundamentally misunderstood. Tens of thousands of lives are lost to snakebites each year and hundreds of thousands of people will survive with some form of permanent damage and reduced work capacity. These numbers are well recognized as being gross underestimations due to poor to non-existent record keeping in some of the most affected areas. These underestimations complicate achieving the proper recognition of snakebite’s socioeconomic impact and thus securing foreign aid to help alleviate this global crisis. Antivenoms are expensive and hospitals are few and far between, leaving people to seek help from traditional healers or use other forms of ineffective treatment. In some cases, cheaper, inappropriately manufactured antivenom from other regions is used despite no evidence for their efficacy, with often robust data demonstrating they are woefully ineffective in neutralizing many venoms for which they are marketed for. Inappropriate first-aid and treatments include cutting the wound, tourniquets, electrical shock, immersion in ice water, and use of ineffective herbal remedies by traditional healers. Even in the developed world, there are fundamental controversies including fasciotomy, pressure bandages, antivenom dosage, premedication such as adrenalin, and lack of antivenom for exotic snakebites in the pet trade. This review explores the myriad of human-origin factors that influence the trajectory of global snakebite causes and treatment failures and illustrate that snakebite is as much a sociological and economic problem as it is a medical one. Reducing the incidence and frequency of such controllable factors are therefore realistic targets to help alleviate the global snakebite burden as incremental improvements across several areas will have a strong cumulative effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.